about
Potentiating cancer immunotherapy using an oncolytic virusAn Introduction to Automated Flow Cytometry Gating Tools and Their ImplementationIL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in miceSurgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceInduction of Epitope-Specific Neutralizing Antibodies against West Nile VirusEpitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part oneCharacterizing complex polysera produced by antigen-specific immunization through the use of affinity-selected mimotopesImmunosenescence in the nursing home elderly.Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop.Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL.Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity.Applying bioinformatics for antibody epitope prediction using affinity-selected mimotopes - relevance for vaccine designEffects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.Processing of tumor antigen differentially impacts the development of helper and effector CD4+ T-cell responsesAssociation between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory studyAlterations to the frequency and function of peripheral blood monocytes and associations with chronic disease in the advanced-age, frail elderly.Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents.Role of dendritic cell-derived cytokines in immune regulation.A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.Surface phenotype and functionality of WNV specific T cells differ with age and disease severity.The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by ageGenetic variants and susceptibility to neurological complications following West Nile virus infection.Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccinesDefining the critical hurdles in cancer immunotherapy.Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent PathwayCombined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patientsRecent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.Kaiso depletion attenuates the growth and survival of triple negative breast cancer cellsDesigned ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors.Chimeric antigen receptor-engineered T cells as oncolytic virus carriers.HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy.T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.T-cell immunity generated by recombinant adenovirus vaccines.Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies.Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccinesCharacterization of Proliferating Lesion-Resident Cells During All Stages of Atherosclerotic Growth.
P50
Q24628810-09392110-DD72-4DE6-88D0-25A01271B570Q26797342-C48ADF15-1727-4565-9494-C9CE2B3084AEQ27311393-2574D645-25C2-4155-B27A-7A3E43887035Q27345519-3789FB69-ACF2-4F10-81E7-7C949E814902Q27484980-6E2E05AD-F56A-4204-BFFA-DB6B87DF57A2Q27485574-CA49D88A-A7D1-4D66-BB72-C1D53A4B469CQ28553703-F60E54BF-9477-40D6-A9B5-0F4A2E70E2DFQ33434406-EA69AC81-2D52-4BB8-8893-A43DAA1C94B8Q33581463-62DDBD3C-2913-4B5A-B20B-E007986A82C0Q33638496-A4BAC4E7-06A6-4474-A31F-398C8F0D4538Q33697909-CA530665-1F4F-49CD-A819-3F9ECB326DF5Q33713083-9AE51C09-BB32-4118-BA61-DEF0667BD2EDQ33713903-D8B87A4E-8409-49AC-9495-D91BB9B7CEF3Q33743491-8F67815D-0467-4E47-A2A7-1F594E0CB94CQ33818929-7FCEEED2-27CE-4820-BFB8-7EC186D66568Q33930126-C8CEE554-C2C7-4E4C-9219-DA49A2EA930EQ33988636-5DCFB62C-6F47-4330-A2F3-B5A5DE131863Q34020484-CE2BAE06-CD1D-44D4-B525-2B34B8F1D9C3Q34282272-031092FD-7C06-4005-B6FD-4B4694FB7BAAQ34319146-35EE3916-B3C7-4886-8AD4-9D6F89747F70Q34331673-584C70A9-185E-4AB5-A235-5F514B3851B9Q34403716-BE134517-1855-41F3-AF8F-BDC1FA10CF9FQ34482074-17B435A8-1F8A-48DD-A7B5-889966A53B6AQ34524651-18CCC5DA-E806-4C08-BF00-B307592C4259Q35466057-02B11186-2605-4525-B99D-25820CDA0AB2Q35876220-A2BEEE81-2D48-4C6C-B8B6-856F00761183Q35916968-D938AA4E-E6BE-4C98-BAE8-A2558252BB4BQ36009231-EA1A9442-2A7A-45B2-80E2-F7FCD7A96194Q36057487-8C564C48-73D7-4C22-9031-034FFAA76F7FQ36297807-4B8906D1-653C-4CA6-99C4-C473D14366DDQ36319385-EEEB8177-C499-494C-8801-103EA33DA802Q36370414-5E70EBC5-E2F6-4DC5-9CBE-B2A035F8F563Q36664258-C22B5620-62BE-499F-A9F1-03E3246A5C36Q36740297-D69A9239-78D4-4AD3-850B-6E47E8BB404EQ36757142-E9A3D417-77AE-4D7C-9A1F-AB461F2E06A3Q36837129-98AC2F71-2EEA-4CE3-9478-AE91735D546DQ37051022-79BFDAD0-6951-4CD6-B838-B6E6F9F65585Q37189696-27D069E8-6A7E-4AE9-8E8B-11B4E44FDD21Q37196054-FCD19C23-9915-4B7C-9B26-70BCC96F3406Q37240505-0DAF4EC2-6C7A-4DE8-9B56-63F49D7A3276
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jonathan L Bramson
@ast
Jonathan L Bramson
@en
Jonathan L Bramson
@es
Jonathan L Bramson
@nl
Jonathan L Bramson
@sl
type
label
Jonathan L Bramson
@ast
Jonathan L Bramson
@en
Jonathan L Bramson
@es
Jonathan L Bramson
@nl
Jonathan L Bramson
@sl
prefLabel
Jonathan L Bramson
@ast
Jonathan L Bramson
@en
Jonathan L Bramson
@es
Jonathan L Bramson
@nl
Jonathan L Bramson
@sl
P106
P21
P31
P496
0000-0003-2874-6886